Sfoglia per Autore
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.
2013-01-01 Falco P;Cavallo F;Larocca A;Rossi D;Guglielmelli T;Rocci A;Grasso M;Siez ML;De Paoli L;Oliva S;Molica S;Mina R;Gay F;Benevolo G;Musto P;Omedè P;Freilone R;Bringhen S;Carella AM;Gaidano G;Boccadoro M;Palumbo A
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results
2013-01-01 Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study.
2014-01-01 Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
2015-01-01 Palumbo, Antonio; Avet-Loiseau, Hervé; Oliva, Stefania; Lokhorst, Henk M; Goldschmidt, Hartmut; Rosinol, Laura; Richardson, Paul; Caltagirone, Simona; Lahuerta, Juan José; Facon, Thierry; Bringhen, Sara; Gay, Francesca; Attal, Michel; Passera, Roberto; Spencer, Andrew; Offidani, Massimo; Kumar, Shaji; Musto, Pellegrino; Lonial, Sagar; Petrucci, Maria T; Orlowski, Robert Z; Zamagni, Elena; Morgan, Gareth; Dimopoulos, Meletios A; Durie, Brian G M; Anderson, Kenneth C; Sonneveld, Pieter; San Miguel, Jésus; Cavo, Michele; Rajkumar, S Vincent; Moreau, Philippe
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial
2015-01-01 Gay, Francesca; Oliva, Stefania; Petrucci, Maria Teresa; Conticello, Concetta; Catalano, Lucio; Corradini, Paolo; Siniscalchi, Agostina; Magarotto, Valeria; Pour, Luděk; Carella, Angelo; Malfitano, Alessandra; Petrò, Daniela; Evangelista, Andrea; Spada, Stefano; Pescosta, Norbert; Omedè, Paola; Campbell, Philip; Liberati, Anna Marina; Offidani, Massimo; Ria, Roberto; Pulini, Stefano; Patriarca, Francesca; Hajek, Roman; Spencer, Andrew; Boccadoro, Mario; Palumbo, Antonio
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
2016-01-01 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis
2017-01-01 Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M.
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis
2017-01-01 Oliva, Stefania; Gambella, Manuela; Gilestro, Milena; Muccio, Vittorio Emanuele; Gay, Francesca; Drandi, Daniela; Ferrero, Simone; Passera, Roberto; Pautasso, Chiara; Bernardini, Annalisa; Genuardi, Mariella; Patriarca, Francesca; Saraci, Elona; Petrucci, Maria Teresa; Pescosta, Norbert; Liberati, Anna Marina; Caravita, Tommaso; Conticello, Concetta; Rocci, Alberto; Musto, Pellegrino; Boccadoro, Mario; Palumbo, Antonio; Omedè, Paola
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma
2018-01-01 Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F.
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives
2018-01-01 Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis
2019-01-01 Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
2020-01-01 Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
2020-01-01 Mina, Roberto; Oliva, Stefania; Boccadoro, Mario
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
2020-01-01 Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H.
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients. | 2013 | Falco P;Cavallo F;Larocca A;Rossi D;Guglielmelli T;Rocci A;Grasso M;Siez ML;De Paoli L;Oliva S;Molica S;Mina R;Gay F;Benevolo G;Musto P;Omedè P;Freilone R;Bringhen S;Carella AM;Gaidano G;Boccadoro M;Palumbo A | |
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results | 2013 | Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A. | |
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. | 2014 | Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A | |
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group | 2015 | Palumbo, Antonio; Avet-Loiseau, Hervé; Oliva, Stefania; Lokhorst, Henk M; Goldschmidt, Hartmut; Rosinol, Laura; Richardson, Paul; Caltagirone, Simona; Lahuerta, Juan José; Facon, Thierry; Bringhen, Sara; Gay, Francesca; Attal, Michel; Passera, Roberto; Spencer, Andrew; Offidani, Massimo; Kumar, Shaji; Musto, Pellegrino; Lonial, Sagar; Petrucci, Maria T; Orlowski, Robert Z; Zamagni, Elena; Morgan, Gareth; Dimopoulos, Meletios A; Durie, Brian G M; Anderson, Kenneth C; Sonneveld, Pieter; San Miguel, Jésus; Cavo, Michele; Rajkumar, S Vincent; Moreau, Philippe | |
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial | 2015 | Gay, Francesca; Oliva, Stefania; Petrucci, Maria Teresa; Conticello, Concetta; Catalano, Lucio; Corradini, Paolo; Siniscalchi, Agostina; Magarotto, Valeria; Pour, Luděk; Carella, Angelo; Malfitano, Alessandra; Petrò, Daniela; Evangelista, Andrea; Spada, Stefano; Pescosta, Norbert; Omedè, Paola; Campbell, Philip; Liberati, Anna Marina; Offidani, Massimo; Ria, Roberto; Pulini, Stefano; Patriarca, Francesca; Hajek, Roman; Spencer, Andrew; Boccadoro, Mario; Palumbo, Antonio | |
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma | 2016 | Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A | |
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis | 2017 | Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M. | |
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis | 2017 | Oliva, Stefania; Gambella, Manuela; Gilestro, Milena; Muccio, Vittorio Emanuele; Gay, Francesca; Drandi, Daniela; Ferrero, Simone; Passera, Roberto; Pautasso, Chiara; Bernardini, Annalisa; Genuardi, Mariella; Patriarca, Francesca; Saraci, Elona; Petrucci, Maria Teresa; Pescosta, Norbert; Liberati, Anna Marina; Caravita, Tommaso; Conticello, Concetta; Rocci, Alberto; Musto, Pellegrino; Boccadoro, Mario; Palumbo, Antonio; Omedè, Paola | |
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma | 2018 | Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F. | |
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives | 2018 | Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter | |
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis | 2019 | Gambella M.; Omede P.; Spada S.; Muccio V.E.; Gilestro M.; Saraci E.; Grammatico S.; Larocca A.; Conticello C.; Bernardini A.; Gamberi B.; Troia R.; Liberati A.M.; Offidani M.; Rocci A.; Palumbo A.; Cavo M.; Sonneveld P.; Boccadoro M.; Oliva S. | |
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate | 2020 | Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G. | |
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives | 2020 | Mina, Roberto; Oliva, Stefania; Boccadoro, Mario | |
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set | 2020 | Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H. | |
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile